A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance
Clinical trial NCT01751984 · COMPLETED
Trial details
- NCT number
- NCT01751984
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-04
- Primary completion
- 2013-05-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.